Concern for severe COVID-19 disease during the initial two years of pandemic in a rural South African community: A population-based study

南非农村社区在新冠疫情最初两年内对重症新冠肺炎的担忧:一项基于人口的研究

阅读:1

Abstract

BACKGROUND: Globally, as of December 2023, over 700 million cases of COVID-19 were confirmed since the initial outbreak late in 2019, claiming around 7 million lives and fuelling widespread fear and anxiety. However, prospective patient-data are unavailable to assess individuals' perceptions of risk of severe COVID-19 illness, which may imply actual disease severity and inform risk perception for future epidemics. METHODS: We surveyed 1701 adults about their concern for severe COVID-19 disease using a population-based survey of rural South Africans. The initial telephonic survey was conducted between August-October 2020 with a follow-up survey conducted between August-October 2021. Multinomial logistic regression was used to investigate predictors of perceived COVID-19 illness severity (low, medium, or high) controlling for measured confounders. RESULTS: The prevalence of concern for COVID-19 illness severity in 2020 was 28.7% low, 26.8% moderate and 44.5% severe, with corresponding levels in 2021 of 42%, 31.8% and 29.2%, respectively. Although older age was associated with a lower odds of COVID-19 concern [50-59 years (aOR=0.54, 95% CI: 0.38-0.75)], [≥60 years (aOR=0.41,95% CI: 0.41-0.57)], adults having ≥1 chronic conditions (aOR=1.38,1.00-1.89) or residing outside of the study community (aOR=1.29,1.01-1.65) were more likely to experience moderate and high concern for illness severity, respectively. CONCLUSIONS: Understanding presumptive COVID-19 disease severity may help disentangle various underlying mechanisms behind personal risk assessment. This may inform current thinking and practice of public health emergency medicine in managing emerging and re-emerging respiratory diseases with pandemic potential such as hPMV.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。